GPT and metabolic dysfunction-associated steatotic liver disease: Morever, some previous studies taking ALT as a serum marker for predicting NAFLD have suggested ALT could be applied to the detection of hepatic diseases (Omagari et al., 2011), but others reported ALT as poor predictor (Verma et al., 2013).